Inflammatory, procoagulant markers and HIV residual viremia in patients receiving protease inhibitor monotherapy or triple drug therapy: a cross-sectional study

Por Estébanez, Miriam, Stella-Ascariz, Natalia, Mingorance, Jesús, Pérez-Valero, Ignacio, Bernardino, Jose Ignacio, Zamora, Francisco Xavier, Montes, Maria Luisa, González-García, Juan Julián, Arribas, José Ramón
Publicado em 2014

Neurocognitive Impairment in Patients Treated with Protease Inhibitor Monotherapy or Triple Drug Antiretroviral Therapy

Por Pérez-Valero, Ignacio, González-Baeza, Alicia, Estébanez, Miriam, Montes-Ramírez, María L., Bayón, Carmen, Pulido, Federico, Bernardino, José I., Zamora, Francisco X., Monge, Susana, Gaya, Francisco, Lagarde, María, Rubio, Rafael, Hernando, Asunción, Arnalich, Francisco, Arribas, José R.
Publicado em 2013

A Prospective Cohort Study of Neurocognitive Function in Aviremic HIV-Infected Patients Treated With 1 or 3 Antiretrovirals

Por Pérez-Valero, Ignacio, González-Baeza, Alicia, Estébanez, Miriam, Monge, Susana, Montes-Ramírez, María L., Bayón, Carmen, Pulido, Federico, Bernardino, José I., Zamora, Francisco X., González-García, Juan J., Lagarde, María, Hernando, Asunción, Arnalich, Francisco, Arribas, José R.
Publicado no Clin Infect Dis (2014)